Chemotherapy dose standardisation: Key therapeutic topic [KTT22]
This document summarises the evidence-base on chemotherapy dose standardisation. It is a key therapeutic topic which has been identified to support medicines optimisation. It is not formal NICE guidance.
https://www.nice.org.uk/advice/ktt22
Thanks to all the BOPA members who have contributed to the implementation support documents.
Don’t miss out, EARLY BIRD RATE until Monday 22nd August 2022 Our first in-person meeting in 3 years will be hosted at the world-renowned ACC in Liverpool, set in the…
BOPA’s pioneering Community Pharmacist Jackie Lewis recently featured in the Chemist and Druggist where her work was described critical to the recovery of cancer services post-pandemic. Jackie is the author…
Dear All, The consent form project team is pleased to announce that the colorectal SACT consent forms have been reviewed and updated. They are available on the CRUK website at:…
We are delighted to announce that we have received a record-breaking number of abstracts for the 2022 Symposium in Liverpool. A crack team of markers are now in the process…
7th to 9th October 2022 at The ACC Liverpool
REGISTRATION NOW OPEN!
Members: www.bopa.org.uk/2022-members-symposium-link/
Non members: Contact Media1Productions: [email protected]
Please see Key information before for accommodation information.
DRAFT AGENDA
Please click here to view the latest agenda.
CONFERENCE FEES (includes VAT)
Early-bird rate applies up until Monday 22nd August 2022
